Urological Endoscopes

Register to receive a free US Market Report Suite for Urological Devices report synopsis and brochure

According to a new series of reports on the U.S. market for urological devices by iData Research, urinary incontinence devices is the largest urological device market, valued at $1.2 billion. This market consists of urinary catheters, urethral bulking agents, incontinence management devices and urinary bags. The second largest and one of the fastest growing segments in terms of market value is the urological endoscope market fueled by the continued shift from fiber scopes to video scopes.

“Much of the urological device market is experiencing moderate growth because the market is well developed; therefore many products are facing average selling price (ASP) declines due to commoditization,” explains Dr. Kamran Zamanian, CEO of iData. “The main exception to this is the benign prostatic hyperplasia (BPH) device market which is the current gold standard for the treatment of urinary incontinence.”

The urological device market has been experiencing moderate growth for the past few years. However, recent regulations have forced hospitals and manufacturers to be wary of the potential for contamination of reusable urological products. This relation of reimbursement to infection rates is driving the disposable, single-use market. Single-use devices traditionally have a higher per use cost, thereby driving up the overall market for many urological segments.

As a result of these institutional changes, steady growth will be seen across the market, especially within prostate cancer treatment devices, urodynamic devices and erectile dysfunction (ED) devices. The main driver for these markets is the aging American population. Additionally, poor lifestyle habits will drive up procedural numbers for these markets. Despite the removal of Medicare coverage for vacuum constriction ED devices, erectile dysfunction has not experienced a decline in overall market value.

Boston Scientific, C.R. Bard and Coloplast were the three largest players within the U.S. urological device market. Collectively, these companies accounted for over 50% of the total market value. Boston Scientific and C.R. Bard gained large market shares due to their strength in multiple urological segments such as stone management and urinary incontinence. Coloplast, in contrast, was involved in only two of the eight urology segments: urinary incontinence and erectile dysfunction. Laborie is particularly dominant within the urodynamics device segment and Olympus leads the urological endoscope market. Additional competitors in the urological device market include Medtronic, Karl Storz, Cook Medical, Astora, Medline, Elekta, Ethicon, Richard Wolf and Varian among others.

For Further Information
More on the urological device market in the United States can be found in a report suite published by iData Research entitled the U.S. Market Report Suite for Urological Devices. The suite covers reports on the following markets: Urinary Incontinence Devices, Stone Management Devices, BPH Treatment Devices, Urological Endoscopes, Prostate Cancer Treatment Devices, Urodynamics Equipment, Nephrostomy Devices, and Erectile Dysfunction.

The iData report series on urological devices covers the U.S., Canada, China, India, Japan, and 15 countries in Europe including Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, the U.K., and Switzerland. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about urology device market data or procedure data, register online or email us at [email protected] for a U.S. Market Report Suite for Urological Devices brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.


Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook: facebook.com/iDataResearch
Follow us on LinkedIn: linkedin.com/company/idata-research
Follow us on Twitter: twitter.com/iDataResearch